SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Anupam Rasayan inks definitive pact to acquire 43.3% stake in Bliss GVS Pharma

25 May 2026 Evaluate

Anupam Rasayan India has entered into a definitive agreement to acquire 43.3-48.2% equity stake + Open Offer to the public shareholders of Bliss GVS Pharma, an India-based pharmaceutical formulations company. The total purchase consideration has been financed via term loan Rs 300 crore and non-controlling non-voting equity instrument for the balance amount.

This will strategically strengthen the company’s presence across the pharmaceutical value chain, spanning KSMs to finished dosage formulations. Bliss GVS Pharma brings well-established capabilities in niche dosage forms, a strong international footprint, differentiated brands, and expertise across multiple therapeutic segments.

Together with the company's advanced chemistry capabilities, the combined platform would create a broader integrated and diversified pharmaceutical manufacturing ecosystem with deeper backward integration, enhanced global reach especially in the Europe and America market, further strengthen by Jayhawk acquisition.

Anupam Rasayan India is one of the leading companies engaged in the custom synthesis (CSM) and manufacturing of specialty chemicals in India.

Anupam Rasayan India Share Price

1342.55 15.95 (1.20%)
04-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
BASF India 3440.35
Tata Chemicals 721.15
SRF 2726.50
Pidilite Inds. 1470.70
Deepak Nitrite 1676.40
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×